With the announcement by Cuban president Miguel Diaz-Canel that in the coming hours there will be more drastic measures to close the capital as the first outbreak of COVID-19, the Public Health Ministry (MINSAP by its Spanish acronym) began today its presentation on the update of the epidemiological situation in Cuba.

Santiago de Cuba, April 5 (ACN) Some 2 thousand Cuban health workers in eastern Santiago de Cuba province are already receiving the first shot of the Cuban COVID-19 vaccine Abdala, as part of an interventional study to immunize front-line workers.

The second dose of the vaccine candidates Soberana 02 and Abdala will be administered today those who volunteered for the Phase III clinical trials, the Cuban Biotechnology and Pharmaceutical Industries Business Group, BioCubaFarma, reported.

Cuba studied 21,200 samples for COVID 19, resulting in 1,066 positive ones. The country accumulates 3, 089,589 samples taken and 80,610 positive.

Doctor of Science Miladys Limonta, manager of the COVID-19 vaccine candidates project of the Center for Genetic Engineering and Biotechnology (CIGB), stressed today in Havana that so far Abdala has demonstrated safety and no serious adverse effects have been reported.

HAVANA, Cuba, Apr 5 (ACN) At the end of April 3, a total of 26,319 patients were admitted, 3,885 were suspected, 17,628 were under surveillance and 4,806 were confirmed active in Cuban hospitals.

Some 40 thousand health workers in the eastern province of Granma are being administered the Cuban COVID-19 vaccine Abdala as part of an interventional study that started Thursday in the local healthcare center Bayamo Oeste.

Cuba studied 20,749 samples for COVID 19, resulting in 1,077 positive ones. The country accumulates 3,025,927 samples taken and 77,353 positive.

Next Monday begins the second dose for volunteers who received the Soberana 02 vaccine candidate on March 8, and successively the rest of the subjects will be immunized, while maintaining the intervention study in Havana with all the necessary rigor and approvals.

Over the past 15 years the number of people diagnosed with Autism Spectrum Disorder (ASD) has grown significantly in Cuba, closing 2020 with 1,661 people; the country joins the celebration every April 2 to raise awareness among the population about this human condition, full of myths and stereotypes.

With the inoculation of CIGB-66, an anti-COVID-19 vaccine candidate by the name of Abdala, to primary and secondary line health workers, the intervention study in this at-risk population began on April 1st in the municipality of Santiago de Cuba in the province of the same name.

The first round of phase III trials with the Cuban COVID-19 candidate vaccine Soberana 02 concluded March 31 in Havana with very good prospects as to safety and the immune response.

Starting today, over 35,000 health professionals from this province will participate in the intervention trial of the Abdala vaccine against COVID-19.

With the development of four new models of pulmonary ventilators, Cuban science guarantees sufficient coverage in the field of ventilation, both for the care of COVID-19 patients, as well as in other medical fields.